These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7585847

  • 1. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
    Katsu K, Yabe S.
    Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
    [Abstract] [Full Text] [Related]

  • 2. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.
    Decktor D, Houle JM, Pierce CH.
    Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044
    [Abstract] [Full Text] [Related]

  • 3. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
    Bruley des Varannes S, Duquesnoy C, Mamet JP, Slama A, Galmiche JP, Scarpignato C.
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
    [Abstract] [Full Text] [Related]

  • 4. Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
    Szabó IL, Czimmer J, Szolcsányi J, Mózsik G.
    Curr Pharm Des; 2013 Nov; 19(1):84-9. PubMed ID: 22946903
    [Abstract] [Full Text] [Related]

  • 5. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS, Witzel L, Walt RP, Neumann J, Scheurle E, Mappes A, Krammisch H, Heim J, Kaufmann D, Roehmel J.
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [Abstract] [Full Text] [Related]

  • 6. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
    Kedziora-Kornatowska K, Tkaczewski W, Blaszczyk J, Buczynski A, Chojnacki J, Kedziora J.
    Hepatogastroenterology; 1998 Jan; 45(19):276-80. PubMed ID: 9496526
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE, West JM, Loft DE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU.
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
    Grimley CE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU.
    Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
    [Abstract] [Full Text] [Related]

  • 11. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
    Amsden GW, Goss TF, Harrison NJ, D'Andrea DT, Schentag JJ.
    J Clin Pharmacol; 1994 Dec; 34(12):1191-8. PubMed ID: 7738215
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose.
    Mallat A, Roudot-Thoraval F, Bergmann JF, Trout H, Simonneau G, Dutreuil C, Blanc LE, Dhumeaux D, Delchier JC.
    Br J Clin Pharmacol; 1994 Feb; 37(2):208-11. PubMed ID: 7910473
    [Abstract] [Full Text] [Related]

  • 13. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
    Gardner JD, Ciociola AA, Robinson M, McIsaac RL.
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
    [Abstract] [Full Text] [Related]

  • 14. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A, Ebrahimzadeh MA, Ahmad-Ashrafi S, Karami M, Mahdavi MR, Saravi SS.
    Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S, Kauffman R, Simpson P, Lehr VT, Lai ML, Sarniak A, Tolia V.
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
    Grimley CE, Constantinides S, Snell CC, Mills JG, Nwokolo CU.
    Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
    [Abstract] [Full Text] [Related]

  • 17. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL, McQuaid KR, Koss MA, Crombie DL, Hunter S, Metz C, Euler AR, Isenberg JI.
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [Abstract] [Full Text] [Related]

  • 18. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
    Hamilton MI, Sercombe J, Pounder RE.
    Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of cimetidine and ranitidine on gastric transmural potential difference and on prolactin secretion in man.
    von Kleist D, Gräf KJ, Dougherty FC, Hampel KE.
    Hepatogastroenterology; 1981 Aug; 28(4):210-2. PubMed ID: 6115806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.